Why lead a company into the increasingly crowded obesity space?

How do you go from a career in veterinary surgery to CEO of a medtech company?

And what is so magical about Oxford when it comes to life science?

Today I’m joined by Camilla Easter, CEO of Oxford Medical Products (OMP), a late-stage medtech company based in Witney, Oxfordshire, in the UK. OMP’s lead product is a non-pharmacological treatment for obesity in overweight patients.

We’ll talk more about the science at the end of the episode, but first Camilla shares her journey to leadership from the vet clinic.

About LifeScience ORG

It’s no secret that Europe is a global leader in generating translational science. We’re grateful at LifeScience ORG to have a community of over 400 life science CEOs – leaders driving change in biotech, medtech, techBio and healthcare.

The conversations inside our community – stories of conviction, navigating challenges, and making bold decisions – inspire us every week. To hear the stories, lessons, and experiences of our life science leaders, listen to A Call to Lead @ LifeScience ORG, available on all good podcasting platforms.

Timestamps

1. Introduction (0:00)
2. From Veterinary Surgery to Biotech Leadership (0:53)
3. The Call to Lead: Finding Your Path (1:50)
4. Career Transitions: Navigating Change (4:30)
5. Stepping Into CEO Role (7:55)
6. Personal Challenges and Defining Moments (10:49)
7. Shared Challenges in Life Science Leadership (15:42)
8. Leadership Lessons: Communication & Community (17:47)
9. The European Life Science Ecosystem (20:39)
10. Tackling the Obesity Crisis: Why This Problem? (21:47)
11. The Technology: A Non-Pharmacological Solution (25:21)
12. Ecosystem Solutions: What We Can Do Together (27:13)
13. A Vision for the Future (33:09)
14. Final Thoughts: Embracing Failure and Learning (35:49)